Sukhtian Ghiath M. - Insider Non-Derivative Transactions at Outlook Therapeutics, Inc. (OTLK) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on May 27, 2025, Sukhtian Ghiath M.'s relationship to Outlook Therapeutics, Inc. (OTLK) is Director,TenPercentOwner, and currently has 13,552,359 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other OTLK insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Sukhtian Ghiath M. - Insider Non-Derivative Transactions of OTLK Common Stock

Sukhtian Ghiath M. - Insider Non-Derivative Transactions at OTLK

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
May 28, 2025	Acquisition -- (Common Stock)	4285714	1.4	13552359
Jan 18, 2025	M -- (Common Stock)	3458571	2.51	9266645
Mar 19, 2024	Acquisition -- (Common Stock)	2305714	0	5808074